AI MRI test to predict treatment response in rectal cancer
Part of Cancer, Digestive system clinical trials.
This study uses an AI computer program to read special MRI images and predict how well treatment (given before surgery) will work for people with locally advanced rectal cancer. It may help doctors better plan who benefits most from neoadjuvant therapy (treatment before surgery).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have rectal cancer confirmed or strongly suspected (from exam/colonoscopy).
- You are 18 years or older.
- You can give written informed consent and agree to be in the study.
- Your MRI images must be clear enough for analysis (not severely blurred by artifacts).
- You should have received neoadjuvant therapy for locally advanced rectal cancer and complete it before surgery, with surgery planned within 2 weeks of the MRI.
- You should not have had prior rectal cancer treatment, other cancers (as a history/combination), or no surgery; and you should be willing to stay in follow-up without withdrawing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
This study uses special MRI scans taken before and during immunotherapy to see if the cancer is truly growing or just appearing to grow, which is called 'pseudoprogression'. It helps doctors better understand how well the treatment is working for rectal cancer.
This study looks at how an MRI “score” (mrTRG) matches how well locally advanced rectal cancer shrinks after pre-surgery chemotherapy and radiation. The goal is to use MRI results to better predict treatment response and guide care.
This study uses MRI scans to try to predict whether your rectal cancer completely disappears after pre-surgery chemoradiotherapy. The goal is to better personalize treatment decisions, possibly helping some patients avoid surgery.
This study uses an AI tool to help doctors make treatment decisions for rectal cancer. It looks at MRI reports and other medical information to suggest the best next steps, like surgery, radiation, or chemotherapy.
This trial uses a special MRI before treatment to better understand early rectal cancer or suspicious large polyps. It may help doctors choose care that avoids bigger surgery when possible.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.